Filing Details
MBX Biosciences, Inc. (NASDAQ:MBX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 06, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:MBX
MBX Biosciences, Inc. (MBX) Files Quarterly Report for Q0
Filing Details MBX Biosciences, Inc. (NASDAQ:MBX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 06, 2026. The Healthcare company…
Market Context
MBX Biosciences, Inc.'s stock currently trades at $67.11 with a market capitalization of $954.7M.
The 10-Q provides MBX Biosciences, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for MBX Biosciences, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MBX Stock Page
Frequently Asked Questions
Where can I read MBX's SEC filings?
Browse all filings on our MBX SEC filings page.
What types of SEC filings does MBX Biosciences, Inc. file?
Public companies like MBX Biosciences, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.